Informe de análisis del tamaño, la participación y las tendencias del mercado mundial de pruebas de susceptibilidad a los antimicrobianos veterinarios: descripción general de la industria y pronóstico hasta 2031

Análisis del mercado de pruebas de susceptibilidad a los antimicrobianos veterinarios

El mercado de pruebas de susceptibilidad a los antimicrobianos veterinarios está experimentando un crecimiento significativo, impulsado por la creciente prevalencia de enfermedades infecciosas tanto en animales de producción de alimentos como en animales de compañía, junto con una mayor conciencia sobre la resistencia a los antibióticos. A medida que los veterinarios y los dueños de mascotas se vuelven más conscientes de la necesidad de un uso eficaz y responsable de los antibióticos, existe una creciente demanda de métodos de prueba precisos que puedan guiar las decisiones de tratamiento. Los avances tecnológicos, como el desarrollo de instrumentos de prueba automatizados y soluciones de prueba rápida, están mejorando la eficiencia y la precisión de las pruebas de susceptibilidad a los antimicrobianos. Además, el apoyo regulatorio y las iniciativas destinadas a promover el uso responsable de antibióticos en la medicina veterinaria están impulsando el crecimiento del mercado. Con una amplia gama de usuarios finales, incluidos laboratorios de referencia veterinarios, institutos de investigación y clínicas, se espera que el mercado se expanda a medida que se introduzcan soluciones de prueba más innovadoras, que aborden la necesidad crítica de un manejo eficaz de las enfermedades infecciosas en los animales.

Tamaño del mercado de pruebas de susceptibilidad a los antimicrobianos veterinarios

El tamaño del mercado mundial de pruebas de susceptibilidad a los antimicrobianos veterinarios se valoró en USD 39,61 mil millones en 2023 y se proyecta que alcance los USD 59,60 mil millones para 2031, con una CAGR del 5,24% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Tendencias del mercado de pruebas de susceptibilidad antimicrobiana veterinaria

“ Creciente énfasis en el uso racional de los antibióticos ”

The veterinary antimicrobial susceptibility testing market is experiencing substantial growth due to rising concerns over antibiotic resistance and the increasing incidence of infectious diseases in both companion and food-producing animals. One significant trend in the market is the growing emphasis on antibiotic stewardship, which encourages responsible antibiotic usage in veterinary practices. As veterinarians strive to optimize treatment outcomes while minimizing the risk of resistance, the demand for precise antimicrobial susceptibility testing is on the rise. In addition, advancements in rapid testing technologies and molecular diagnostics are enhancing the speed and accuracy of these tests, further driving market growth. Overall, the veterinary antimicrobial susceptibility testing market is poised for continued expansion as innovations in testing methods and a focus on stewardship reshape the landscape of veterinary care.

Report Scope and Veterinary Antimicrobial Susceptibility Testing Market Segmentation

Veterinary Antimicrobial Susceptibility Testing Market Definition

Veterinary Antimicrobial Susceptibility Testing (VAST) refers to a laboratory procedure used to determine the effectiveness of antimicrobial agents against specific bacteria or pathogens isolated from animals. This testing helps veterinarians identify which antibiotics or antimicrobial drugs are most effective in treating infections in animals, ensuring appropriate treatment choices that can improve animal health and reduce the risk of antibiotic resistance. VAST plays a critical role in veterinary medicine, particularly in managing infectious diseases, guiding treatment protocols, and promoting responsible use of antimicrobials in animal husbandry.

Veterinary Antimicrobial Susceptibility Testing Market Dynamics

Drivers

• Rising Prevalence of Antimicrobial Resistance

The rising prevalence of antimicrobial resistance (AMR) in animals is a critical market driver for the veterinary antimicrobial susceptibility testing (AST) sector. AMR poses a serious threat to animal health and welfare and undermines the effectiveness of antimicrobial treatments, leading to prolonged illness and increased mortality rates among livestock and pets. Veterinary antimicrobial susceptibility testing plays a vital role in this context by identifying the most effective antimicrobial agents for treating infections, thus helping to combat the challenge of AMR. By using AST, veterinarians can tailor treatment plans to ensure the selection of appropriate antimicrobials, improving treatment outcomes and minimizing the risk of resistance development. Such growing recognition of the importance of AST in managing AMR is driving demand in the veterinary sector, thereby significantly contributing to the expansion of the veterinary antimicrobial susceptibility testing market.

• Increasing Incidence of Infectious Diseases

The increasing incidence of infectious diseases among both companion and food-producing animals is a major driver of the veterinary antimicrobial susceptibility testing market. As outbreaks of infections such as canine parvovirus and feline leukemia become more common, veterinarians are faced with the challenge of effectively diagnosing and treating these diseases. For instance, a report from the American Veterinary Medical Association indicated that there has been a noticeable rise in antibiotic-resistant bacterial infections in livestock, necessitating the use of precise antimicrobial susceptibility testing to identify effective treatment options. This growing prevalence of infectious diseases heightens the demand for accurate testing and underscores the importance of tailored therapeutic approaches in veterinary medicine. As a result, the urgency to manage these infectious diseases effectively is propelling the market for antimicrobial susceptibility testing solutions, reinforcing the need for advanced diagnostic tools in veterinary practices.

Opportunities

• Increasing Adoption of Point-of-Care Testing

Point-of-care testing (POCT) involves performing diagnostic tests and obtaining results in real-time at the site of patient care. The adoption of POCT in veterinary medicine is on the rise, presenting a significant opportunity for the development of portable and user-friendly antimicrobial susceptibility testing devices that can be utilized directly in veterinary clinics or in the field. These rapid testing solutions offer immediate results, enabling veterinarians to make prompt treatment decisions based on the specific antimicrobial resistance patterns of the pathogens involved. This capability enhances the quality of care provided to animals and contributes to more effective disease management and better patient outcomes. By facilitating timely interventions, POCT can play a crucial role in improving overall animal health and welfare.

• Expansion of Veterinary Reference Laboratories

Veterinary reference laboratories are essential in delivering specialized diagnostic services, particularly antimicrobial susceptibility testing, to veterinary clinics and hospitals. As the demand for precise and comprehensive diagnostic testing rises, these laboratories have a significant opportunity for expansion. By investing in advanced testing technologies, such as automated systems and molecular diagnostics, veterinary reference labs can enhance their efficiency and accuracy in diagnosing infections. In addition, expanding their testing capacities enables them to accommodate a larger volume of samples and offer a broader array of antimicrobial susceptibility testing services. Such strategic growth helps meet the increasing market demand and supports veterinarians in making informed treatment decisions, ultimately improving animal health outcomes and promoting responsible antibiotic use in veterinary medicine.

Restraints/Challenges

• High Costs of Antimicrobial Susceptibility Testing

The high costs associated with antimicrobial susceptibility testing represent a significant barrier for veterinary clinics, particularly in developing regions where budget constraints restrict access to advanced diagnostics. Many veterinary practices, especially smaller clinics, may find it challenging to invest in the necessary testing equipment and reagents, which can be prohibitively expensive. This financial hurdle can lead to a reliance on traditional treatment methods without the benefit of tailored antimicrobial therapy, potentially resulting in ineffective treatment outcomes and contributing to the rise of antimicrobial resistance. As a consequence, the lack of affordable testing options limits the overall adoption of antimicrobial susceptibility testing in veterinary medicine. This challenge hampers market growth, as the inability to conduct effective testing may undermine efforts to improve animal health and welfare.

• Stringent Regulatory Standards

The veterinary antimicrobial susceptibility testing market encounters significant regulatory hurdles that can impede the approval and commercialization of new diagnostic products. Stringent regulatory requirements often necessitate extensive clinical trials and comprehensive documentation to demonstrate the safety and efficacy of testing devices and procedures. These lengthy processes can delay the introduction of innovative solutions into the market, which is critical for addressing emerging challenges related to antimicrobial resistance in veterinary medicine. Furthermore, navigating the complex landscape of regulations across different countries can be daunting for companies, especially smaller firms lacking the resources to manage compliance effectively. As a result, these regulatory challenges can hinder the timely availability of advanced diagnostic tools, limiting the market's growth and reducing veterinarians' ability to implement effective antimicrobial stewardship practices.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Veterinary Antimicrobial Susceptibility Testing Market Scope

The market is segmented on the basis of product type, animal type, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Disks and Plates
• Culture Media
• Accessories and Consumables
• Automated Antimicrobial Susceptibility Testing Instruments

Animal Type

• Food-producing Animals
  • Cattle
  • Poultry
  • Pigs
  • Others (Sheep, Goats, Veal)
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others (Birds, Fish, Turtles)

End User

• Veterinary Reference Laboratory
• Veterinary Research Institutes and Universities
• Others

Veterinary Antimicrobial Susceptibility Testing Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, animal type, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the global veterinary antimicrobial susceptibility testing market due to its robust and advanced healthcare infrastructure, particularly in veterinary care. The region is equipped with an extensive network of veterinary clinics, diagnostic laboratories, and research institutions, all of which possess the resources and expertise required to conduct antimicrobial susceptibility testing effectively.

Asia-Pacific region is anticipated to experience significant growth from 2024 to 2031, driven by its large and expanding population that is increasingly demanding animal protein, such as meat, milk, and eggs. The intensification of animal production systems and the higher density of livestock can lead to the spread of infectious diseases and antimicrobial resistance. Consequently, there is an escalating need for effective diagnostics, including antimicrobial susceptibility testing, to safeguard the health and productivity of livestock and aquaculture.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Veterinary Antimicrobial Susceptibility Testing Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Veterinary Antimicrobial Susceptibility Testing Market Leaders Operating in the Market Are:

• BD (U.S.)
• Synbiosis (U.S.)
• Zhuhai DL Biotech Co., Ltd. (China)
• Mast Group Ltd. (U.K.)
• HiMedia Laboratories (India)
• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Creative Diagnostics (U.S.)
• Genefluidics, Inc. (U.S.)
• ROSCO DIOGNISTICA (Germany)
• Erba Mannheim (U.S.)
• Liofilchem S.r.l. (Italy)
• Alifax S.r.l. (Italy)
• MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany)
• BIOMÉRIEUX (France)
• Merck KGaA (U.S.)
• Danaher (U.S.)
• Accelerate Diagnostics, Inc. (U.S.)
• NuMedii, Inc. (U.S.)

Latest Developments in Veterinary Antimicrobial Susceptibility Testing Market

• In June 2023, bioMérieux achieved a remarkable milestone by receiving nine IMV ServiceTrak clinical laboratory awards. These awards recognized the company’s excellence across several key segments, including Immunoassay, ID/AST, and Blood Culture, highlighting its commitment to delivering high-quality diagnostic solutions and reinforcing its leadership position in the clinical laboratory market
• In April 2023, Bio-Rad Laboratories, Inc. introduced the ID-Check Speciation Solution, a cutting-edge tool designed to determine the animal species origin of meat samples. This innovative solution is invaluable for food, feed, and environmental testing, ensuring accurate identification and enhancing food safety and traceability in the supply chain
• En octubre de 2022, Bioguard Corporation alcanzó un hito importante al recibir la acreditación ISO 17025 para su centro de diagnóstico de salud animal. Esta acreditación subraya el compromiso de la organización de mantener altos estándares en las prácticas de laboratorio, asegurando que sus servicios de diagnóstico cumplan con los requisitos de calidad internacionales y sean confiables para los profesionales veterinarios.
• En agosto de 2022, Becton, Dickinson and Company firmó un acuerdo de colaboración comercial con Accelerate Diagnostics, Inc. Esta asociación estratégica tiene como objetivo mejorar la distribución de la cartera integral de productos de resistencia y susceptibilidad a los antibióticos de Accelerate, mejorando así el acceso a herramientas de diagnóstico avanzadas que son cruciales para el manejo eficaz de las infecciones.
• En junio de 2021, bioMérieux firmó un acuerdo de distribución con Specific Diagnostics para distribuir su sistema REVEAL Rapid AST en toda Europa. Esta asociación permite a bioMérieux ampliar su cartera de soluciones de pruebas de susceptibilidad a los antimicrobianos, mejorando su capacidad para ofrecer diagnósticos rápidos y precisos a los proveedores de atención médica de la región.

SKU-66356